Mitra Mosharraf

Dr. Mitra Mosharraf is Chief Scientific Officer at HTD Biosystems and cofounder of Engimata Inc., with prior scientific leadership roles at Pharmacia, Pfizer, and Santen. She holds a Ph.D. in Pharmaceutical Sciences (Uppsala University), an MBA from MIT, and certificates in Business Analytics, AI in Biotech and Pharma (MIT), and Executive Leadership (Cornell). Dr. Mosharraf is an inventor on six patents related to liposomal vaccines and nanocrystals, co-author of over 20 publications, and the 2024–2025 Chair of the AAPS Nanotechnology Community.